课题基金 / 基金详情

Thrombin-induoed vascular injury through the overproduction of reactive oxygen species

Thrombin-induoed vascular injury through the overproduction of reactive oxygen species
活性氧过量产生凝血酶引起的血管损伤
批准号:
12670674
负责人:
AKAIKE Masashi
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

AKAIKE Masashi的其他基金

相似基金

相关文献

中文摘要
翻译
为探讨凝血酶对血管内皮细胞活性氧(ROS)产生的影响,采用荧光探针DCFH-DA检测了培养的人脐静脉内皮细胞(HUVEC)细胞内过氧化氢(H2 O2)的含量。1U/ml凝血酶作用HUVEC 24小时,ROS水平增加至对照组的2倍。羰基氰化物间氯苯腙,用于降低线粒体膜质子梯度和噻吩甲酰三氟丙酮,复合物II抑制剂的代理,显着抑制凝血酶处理的HUVEC中的ROS的过度产生。奎纳克林,NADPH氧化酶的抑制剂,也显着抑制ROS的过度产生。与此相反,没有显着的抑制作用,吲哚美辛,环氧合酶的抑制剂,或L-NAME,一氧化氮合酶的抑制剂,观察。复合物I的抑制剂DPI和复合物III的抑制剂myxothiazol也没有表现出对ROS产生的显著影响。共聚焦激光显微镜成像显示DCFH-DA的绿色荧光与Mitotracker Red的红色荧光共定位,表明线粒体产生过氧化氢。阿司匹林(1 mM)预处理可明显抑制凝血酶处理的HUVEC产生ROS,提示凝血酶可引起HUVEC线粒体呼吸链和NADPH氧化酶产生ROS,进而消耗NO,导致血管内皮细胞损伤。此外,阿司匹林可保护血管内皮细胞免受Trombin诱导的ROS产生的损伤。
英文摘要
To clarify the effect of thrombin on the production of reactive oxygen species (ROS) in vasular endothelial cells, we analyzed intracellular amount of hydrogen peroxide in cultured human umbilical vein endothelial cells (HUVEC) using the fluorescence probe (DCFH-DA). In HUVEC, ROS was increased up to two-folds of control by the treatment of 1U/ml thrombin for 24 hours. Carbonyl cyanide m-chlorophenylhyazone, an agent for decreasing the mitochondrial membrane proton gradient and thenoyltrifluoroacetone, a complex II inhibitor, markedly suppressed the overproduction of ROS in thrombin-treated HUVEC. Quinacrine, an inhibitor for NADPH oxidase, also significantly suppressed the overproduction of ROS. In contrast, no significant inhibitory effects of indomethacin, an inhibitor for cyclooxygenase, or of L-NAME, an inhibitor for NO synthase, were observed. DPI, an inhibitor for complex I, and myxothiazol, an inhibitor for complex III, also did not exhibit a significant effect on the production of ROS. Con focal laser microscopy imaging showed that green fluoresscence of DCFH-DA colocalized with red fluorescence of Mitotracker Red, indicating hydrogen peroxide production from mitochondria. Pre-treatment of aspirin (1mM) markedly suppressed the ROS production in thrombin-treated HUVEC.These findings showed that thrombin could cause the overproduction of ROS from mitochondrial respiratory chain and NADPH oxidase, and subsequently the consumption of NO in vascular endothelial cells, leading to injury of vscular endothelial cells. In addition, aspirin may protect vascular endothelial cells from damage by trombin-induced ROS poduction.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
Kuroda Y. et al.: "Homozygous deletion mutation of the parkin gene in patients with atypical parkinsonism"J Neurol Neurosurg Psychiatry. 71. 231-234 (2001)
Kuroda Y. 等人:“非典型帕金森病患者的帕金基因纯合缺失突变”J Neurol Neurosurg Psychiatry。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Umaki Y, et al.: "Apoptosis-related changes in skeletal muscles of patients with mitochondrial diseases"Acta Neuropathol. 103. 163-170 (2002)
Umaki Y 等人:“线粒体疾病患者骨骼肌细胞凋亡相关的变化”Acta Neuropathol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kanagawa Y, et al.: "Molecular mechanism of type I congenital heparin cofactor (HC) II deficiency caused by a missense mutation at reactive P2 site : HC II Tokushima"Thromb Haemost. 85. 101-107 (2001)
Kanakawa Y 等人:“由反应性 P2 位点错义突变引起的 I 型先天性肝素辅因子 (HC) II 缺乏症的分子机制:HC II 德岛”血栓 Haemost。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Aihara K, et al.: "Successful combination therapy-Flunarizine, pentoxifyline, and Cholestyramine-For spur cell anemia"Int J Hematol. 73. 351-355 (2001)
Aihara K 等人:“成功的联合疗法——氟桂利嗪、己酮可可碱和考来烯胺——治疗刺激细胞贫血”Int J Hematol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
7
    Development of training program introducing clinical clerkship to acquire 360 degree communication skills and abilities
    • 批准号:
      15K08554
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2015
    • 负责人:
      AKAIKE Masashi
    • 依托单位:
    Glucocorticoid-induced vascular endothelial dysfunction through activation of mineralcorticoid receptor
    • 批准号:
      21590955
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2009
    • 负责人:
      AKAIKE Masashi
    • 依托单位:
    A novel therapeutic strategy for glucocorticoid-induced vascula endothelial dysfundtion
    • 批准号:
      19590866
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2007
    • 负责人:
      AKAIKE Masashi
    • 依托单位:
    Novel regulatory mechanism of vascular endothelial function mediated by BMK1/ERK5 and its application for anti-atherosclerosis therapy
    • 批准号:
      17590740
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      2005
    • 负责人:
      AKAIKE Masashi
    • 依托单位:
    海外基金